LN-020

N/A

Report date: 2025/04/28 22:35:30
NME

Base Information

Drug NameLN-020
Drug Alias NameLN020LN-020
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsInfluenza A virus infectionsInfluenza, HumanInfluenza B virus infection
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesShandong Luning Pharmaceutical Co Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesShandong Luning Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsInfluenza A virus infectionsInfluenza, HumanInfluenza B virus infection
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A